GNH USA

Europe — EMA

Maryzola

GNH USA supplies Maryzola (Memantine), a NMDA receptor antagonist for Alzheimer's disease treatment. Request a quote for global supply to providers worldwide.

Memantine Hydrochloride

Request sourcing

1
Pack/s

What is Memantine Hydrochloride?

Memantine, the active ingredient in Maryzola, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adult patients, helping to mitigate cognitive decline and functional impairment associated with the condition.

GNH USA supplies Maryzola as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Clients benefit from consistent product availability and regulatory support across multiple markets.

What is Memantine Hydrochloride used for?

Memantine is used in the management of Alzheimer’s disease, targeting glutamatergic neurotransmission to improve clinical outcomes.

Mild to moderate Alzheimer’s disease: helps maintain cognitive function and daily activities Moderate to severe Alzheimer’s disease: supports functional abilities and slows progression Behavioral symptoms of Alzheimer’s disease: may reduce agitation and improve patient cooperation

What are the side effects of Memantine Hydrochloride?

Memantine may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion

Serious or Rare Side Effects: - Seizures - Arrhythmia - Severe allergic reaction (anaphylaxis)

What precautions apply to Memantine Hydrochloride?

When prescribing memantine, clinicians should consider several safety aspects.

Renal impairment: monitor renal function and adjust therapy as needed History of seizures: observe for increased seizure activity Cardiovascular disease: assess blood pressure regularly Concurrent use with other NMDA antagonists: avoid combined therapy Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment Store at ambient temperature: keep in original packaging, protect from moisture and heat

What does Memantine Hydrochloride interact with?

Memantine can interact with other medicines; some combinations require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Amantadine: additive NMDA antagonism may increase neurotoxicity - Ketamine: combined NMDA blockade can cause severe CNS depression - High-dose zinc supplements: may reduce memantine absorption

Moderate Interactions (Monitor Closely): - Antihypertensive agents: memantine may enhance blood pressure‑lowering effect - Diuretics: potential electrolyte disturbances - Other central nervous system depressants: may increase dizziness and somnolence

Frequently asked questions

What is Maryzola used for?+
Maryzola contains memantine hydrochloride and is prescribed for the treatment of Alzheimer’s disease. It is used to help maintain cognitive function and support daily living activities in patients with mild to moderate or moderate to severe disease, and may also alleviate certain behavioral symptoms associated with the condition.
How does memantine work?+
Memantine works by binding to the NMDA‑type glutamate receptor channel as a non‑competitive antagonist. This blocks excessive calcium entry that occurs during prolonged glutamate stimulation, reducing excitotoxic neuronal damage while preserving normal synaptic transmission, which contributes to its therapeutic effect in Alzheimer’s disease.
What is the usual dose of Maryzola?+
The appropriate dose of Maryzola is determined by the prescribing healthcare professional based on the individual’s clinical condition, age, renal function and other factors. Physicians typically start with a low dose and may titrate upward, but the exact regimen should be followed as directed on the prescription label.
Is Maryzola safe during pregnancy or breastfeeding?+
Safety data for memantine in pregnancy and lactation are limited. The product should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their healthcare provider.
How do I order Maryzola from GNH USA?+
To place an order, submit an enquiry on the Maryzola product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams across international markets. After submission, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details and any required import documentation.
How does Maryzola compare with the main alternative drug or class?+
The primary alternative class for Alzheimer’s disease is acetylcholinesterase inhibitors such as donepezil. While both classes aim to improve cognition, memantine targets glutamatergic excitotoxicity, whereas acetylcholinesterase inhibitors enhance cholinergic transmission. Clinical practice often uses memantine alone for moderate‑to‑severe disease or in combination with an acetylcholinesterase inhibitor for broader symptom control.
How should Maryzola be stored and handled?+
Maryzola tablets should be stored at ambient temperature, below 25 °C, in the original container to protect them from moisture and heat. Keep the product out of reach of children and avoid exposure to direct sunlight. No special refrigeration is required.
How is Maryzola given or administered?+
Maryzola is administered orally as a tablet. Patients should swallow the tablet whole with water, with or without food, unless otherwise instructed by their prescriber. The dosage schedule, including any titration steps, must follow the prescribing information provided by the treating physician.
What are the most serious risks to watch for while taking Maryzola?+
Serious adverse reactions, although uncommon, include seizures, cardiac arrhythmias and severe allergic responses such as anaphylaxis. Patients should seek immediate medical attention if they experience convulsions, irregular heartbeats, rash, swelling of the face or throat, or difficulty breathing while on therapy.
Who should not use Maryzola?+
Maryzola should not be used by individuals with known hypersensitivity to memantine or any excipients in the tablet. It is also contraindicated in patients with severe renal impairment where dosing cannot be appropriately adjusted, and in those taking other NMDA‑receptor antagonists due to the risk of additive neurotoxicity.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Memantine Hydrochloride
Route
Oral Use
Manufacturer
Tad Pharma Gmbh
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU